Work productivity in rhinitis using cell phones: The <scp>MASK</scp> pilot study
-
- J. Bousquet
- MACVIA‐France Contre les MAladies Chroniques pour un VIeillissement Actif en France European Innovation Partnership on Active and Healthy Ageing Reference Site Montpellier France
-
- M. Bewick
- iQ4U Consultants Ltd London UK
-
- S. Arnavielhe
- Kyomed Montpellier France
-
- E. Mathieu‐Dupas
- Kyomed Montpellier France
-
- R. Murray
- Medical Communications Consultant MedScript Ltd Dundalk Co. Louth Ireland
-
- A. Bedbrook
- MACVIA‐France Contre les MAladies Chroniques pour un VIeillissement Actif en France European Innovation Partnership on Active and Healthy Ageing Reference Site Montpellier France
-
- D. P. Caimmi
- Sorbonne Universités UPMC Paris 06 UMR‐S 1136 IPLESP Equipe EPAR Paris France
-
- O. Vandenplas
- Department of Chest Medicine Centre Hospitalier Universitaire UCL Namur Université Catholique de Louvain Yvoir Belgium
-
- P. W. Hellings
- Laboratory of Clinical Immunology Department of Microbiology and Immunology KU Leuven Leuven Belgium
-
- C. Bachert
- Upper Airways Research Laboratory ENT Department Ghent University Hospital Ghent Belgium
-
- J. M. Anto
- ISGLoBAL Centre for Research in Environmental Epidemiology (CREAL) IMIM (Hospital del Mar Research Institute) CIBER Epidemiología y Salud Pública (CIBERESP) & Universitat Pompeu Fabra (UPF) Barcelona Spain
-
- K. C. Bergmann
- Global Allergy and Asthma European Network (GA<sup>2</sup>LEN) Comprehensive Allergy‐Centre‐Charité Department of Dermatology and Allergy Charité – Universitätsmedizin Berlin Berlin Germany
-
- C. Bindslev‐Jensen
- Department of Dermatology and Allergy Centre Odense University Hospital Odense Denmark
-
- S. Bosnic‐Anticevich
- Woolcock Institute of Medical Research University of Sydney and Sydney Local Health District Glebe NSW Australia
-
- J. Bouchard
- Laval's Unit Clinical Medicine Quebec City QC Canada
-
- G. W. Canonica
- Personalized Medicine Clinic Asthma & Allergy Humanitas University Humanitas Research Hospital Rozzano Milano Italy
-
- N. H. Chavannes
- Department of Public Health and Primary Care Leiden University Medical Center Leiden The Netherlands
-
- A. A. Cruz
- ProAR – Nucleo de Excelencia em Asma Federal University of Bahia Bahia Brazil
-
- R. Dahl
- ProAR – Nucleo de Excelencia em Asma Federal University of Bahia Bahia Brazil
-
- P. Demoly
- Department of Respiratory Diseases Montpellier University Hospital Montpellier France
-
- G. De Vries
- Peercode DV Gerdermalsen The Netherlands
-
- P. Devillier
- Laboratoire de Pharmacologie Respiratoire UPRES EA220 Pôle des Maladies Respiratoires Hôpital Foch Suresnes France
-
- A. Fink‐Wagner
- Global Allergy and Asthma Platform GAAPP Vienna Austria
-
- W. J. Fokkens
- Department of Otorhinolaryngology Academic Medical Centre Amsterdam The Netherlands
-
- J. Fonseca
- Center for Health Technology and Services Research‐ CINTESIS Faculdade de Medicina Universidade do Porto Porto Portugal
-
- N. A. Guldemond
- Institute of Health Policy and Management iBMG Erasmus University Rotterdam The Netherlands
-
- T. Haahtela
- Skin and Allergy Hospital Helsinki University Hospital Helsinki Finland
-
- B. Hellqvist‐Dahl
- Department of Respiratory Diseases Odense University Hospital Odense Denmark
-
- J. Just
- Allergology Department Centre de l'Asthme et des Allergies. Hôpital d'Enfants Armand‐Trousseau (APHP) Paris France
-
- T. Keil
- Institute of Social Medicine, Epidemiology and Health Economics Charité – Universitätsmedizin Berlin Berlin Germany
-
- L. Klimek
- Center for Rhinology and Allergology Wiesbaden Germany
-
- M. L. Kowalski
- Department of Immunology, Rheumatology and Allergy Medical University of Lodz Lodz Poland
-
- P. Kuna
- Division of Internal Medicine, Asthma and Allergy Barlicki University Hospital Medical University of Lodz Lodz Poland
-
- V. Kvedariene
- Clinic of Infectious, Chest Diseases, Dermatology and Allergology Vilnius University Vilnius Lithuania
-
- D. Laune
- Kyomed Montpellier France
-
- D. Larenas‐Linnemann
- Clínica de Alergia, Asma y Pediatría Hospital Médica Sur México City Mexico
-
- J. Mullol
- Clinical & Experimental Respiratory Immunoallergy ENT Department Hospital Clínic IDIBAPS Universitat de Barcelona Barcelona Spain
-
- A. M. Pereira
- Immunoallergy Department CUF‐Descobertas Hospital Lisbon Portugal
-
- P. Carreiro‐Martins
- CEDOC Respiratory Research Group Nova Medical School Campo dos Martires da Patria Lisbon Portugal
-
- E. Melén
- Sachs’ Children and Youth Hospital Södersjukhuset Institute of Environmental Medicine Karolinska Institutet Stockholm Sweden
-
- M. Morais‐Almeida
- Allergy and Clinical Immunology Department Hospital CUF‐Descobertas Lisboa Portugal
-
- L. Nogueira‐Silva
- Center for Health Technology and Services Research – CINTESIS and Department of Internal Medicine Centro Hospitalar Sao Joao Porto Portugal
-
- R. E. O'Hehir
- Department of Allergy, Immunology and Respiratory Medicine Alfred Hospital and Central Clinical School Monash University Melbourne Vic. Australia
-
- N. G. Papadopoulos
- Center for Pediatrics and Child Health Institute of Human Development Royal Manchester Children's Hospital University of Manchester Manchester UK
-
- G. Passalacqua
- Allergy and Respiratory Diseases IRCCS San Martino‐IST‐University Genoa Italy
-
- F. Portejoie
- MACVIA‐France Contre les MAladies Chroniques pour un VIeillissement Actif en France European Innovation Partnership on Active and Healthy Ageing Reference Site Montpellier France
-
- D. Price
- Observational and Pragmatic Research Institute Singapore City Singapore
-
- D. Ryan
- Allergy and Respiratory Research Group Usher Institute of Population Health Sciences and Informatics University of Edinburgh Edinburgh UK
-
- B. Samolinski
- Department of Prevention of Environmental Hazards and Allergology Medical University of Warsaw Warsaw Poland
-
- A. Sheikh
- Centre of Medical Informatics Usher Institute of Population Health Sciences and Informatics The University of Edinburgh Edinburgh UK
-
- F. E. R. Simons
- Departments of Pediatrics & Child Health and Immunology Faculty of Medicine University of Manitoba Winnipeg MB Canada
-
- O. Spranger
- Global Allergy and Asthma Platform GAAPP Vienna Austria
-
- A. Todo Bom
- Imunoalergologia Centro Hospitalar Universitário de Coimbra and Faculty of Medicine University of Coimbra Coimbra Portugal
-
- P. V. Tomazic
- Department of ENT Medical University of Graz Graz Austria
-
- M. Triggiani
- Division of Allergy and Clinical Immunology University of Salerno Salerno Italy
-
- A. Valero
- Pneumology and Allergy Department Ciberres and Clinical & Experimental Respiratory Imunoallergy IDIBAPS Universitat Barcelona Barcelona Spain
-
- E. Valovirta
- Department of Lung Diseases and Clinical Immunology University of Turku Turku Finland
-
- A. Valiulis
- Vilnius University Clinic of Children's Diseases and Public Health Institute Vilnius Lithuania
-
- M. van Eerd
- Peercode DV Gerdermalsen The Netherlands
-
- M. Wickman
- Sachs’ Children and Youth Hospital Södersjukhuset Institute of Environmental Medicine Karolinska Institutet Stockholm Sweden
-
- I. Young
- Queen's University Belfast Belfast UK
-
- T. Zuberbier
- Global Allergy and Asthma European Network (GA<sup>2</sup>LEN) Comprehensive Allergy‐Centre‐Charité Department of Dermatology and Allergy Charité – Universitätsmedizin Berlin Berlin Germany
抄録
<jats:title>Abstract</jats:title><jats:p>Allergic rhinitis often impairs social life and performance. The aim of this cross‐sectional study was to use cell phone data to assess the impact on work productivity of uncontrolled rhinitis assessed by visual analogue scale (<jats:styled-content style="fixed-case">VAS</jats:styled-content>). A mobile phone app (<jats:italic>Allergy Diary,</jats:italic> Google Play Store and Apple App Store) collects data from daily visual analogue scales (<jats:styled-content style="fixed-case">VAS</jats:styled-content>) for overall allergic symptoms (<jats:styled-content style="fixed-case">VAS</jats:styled-content>‐global measured), nasal (<jats:styled-content style="fixed-case">VAS</jats:styled-content>‐nasal), ocular (<jats:styled-content style="fixed-case">VAS</jats:styled-content>‐ocular) and asthma symptoms (<jats:styled-content style="fixed-case">VAS</jats:styled-content>‐asthma) as well as work (<jats:styled-content style="fixed-case">VAS</jats:styled-content>‐work). A combined nasal‐ocular score is calculated. The <jats:italic>Allergy Diary</jats:italic> is available in 21 countries. The app includes the Work Productivity and Activity Impairment Allergic Specific Questionnaire (<jats:styled-content style="fixed-case">WPAI</jats:styled-content>:<jats:styled-content style="fixed-case">AS</jats:styled-content>) in six <jats:styled-content style="fixed-case">EU</jats:styled-content> countries. All consecutive users who completed the <jats:styled-content style="fixed-case">VAS</jats:styled-content>‐work from 1 June to 31 October 2016 were included in the study. A total of 1136 users filled in 5818 days of <jats:styled-content style="fixed-case">VAS</jats:styled-content>‐work. Symptoms of allergic rhinitis were controlled (<jats:styled-content style="fixed-case">VAS</jats:styled-content>‐global <20) in approximately 60% of the days. In users with uncontrolled rhinitis, approximately 90% had some work impairment and over 50% had severe work impairment (<jats:styled-content style="fixed-case">VAS</jats:styled-content>‐work >50). There was a significant correlation between <jats:styled-content style="fixed-case">VAS</jats:styled-content>‐global calculated and <jats:styled-content style="fixed-case">VAS</jats:styled-content>‐work (Rho=0.83, <jats:italic>P</jats:italic><0.00001, Spearman's rank test). In 144 users, there was a significant correlation between <jats:styled-content style="fixed-case">VAS</jats:styled-content>‐work and <jats:styled-content style="fixed-case">WPAI</jats:styled-content>:<jats:styled-content style="fixed-case">AS</jats:styled-content> (Rho=0.53, <jats:italic>P</jats:italic><0.0001). This pilot study provides not only proof‐of‐concept data on the work impairment collected with the app but also data on the app itself, especially the distribution of responses for the <jats:styled-content style="fixed-case">VAS</jats:styled-content>. This supports the interpretation that persons with rhinitis report both the presence and the absence of symptoms.</jats:p>
収録刊行物
-
- Allergy
-
Allergy 72 (10), 1475-1484, 2017-06-09
Wiley